Pure Global

IGFBP-3 Control(IDS-iSYS Insulin-like Growth Factor Binding Protein 3 Control Set) - India CDSCO Medical Device Registration

IGFBP-3 Control(IDS-iSYS Insulin-like Growth Factor Binding Protein 3 Control Set) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000339_ecf71ecd67f3f67bd1ed3e2551e96597_72bc126850d00ff769083bd35f3862fd. This device is marketed under the brand name CTX-I. The license holder is CPC DIAGNOSTICS PVT.LTD, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
IGFBP-3 Control(IDS-iSYS Insulin-like Growth Factor Binding Protein 3 Control Set)
UID: IMP/IVD/2022/000339_ecf71ecd67f3f67bd1ed3e2551e96597_72bc126850d00ff769083bd35f3862fd

Brand Name

CTX-I

Device Class

Class B

Approving Authority

CDSCO

Product Information

The IDS-iSYS Insulin-like Growth Factor Binding Protein 3 (CTX-I) Control Set is for in vitro diagnostic use, for the quality control of the IDS-iSYS Insulin-like Growth Factor Binding Protein 3 (CTX-I) assay on the IDS systems

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing